Graft microvasculature is a major target of donor-specific antibodies (DSA) and endothelial damage is direct evidence of antibody-mediated rejection (ABMR). Using immunohistochemistry, we analyzed the expression of three microvascular endothelial activation markers (fascin, vimentin, and hsp47), suggestive of endothelial-to-mesenchymal transition (EndMT) in 351 graft biopsies from 248 kidney recipients, with concomitant screening of circulating antihuman leukocyte antigen (HLA) DSA at the time of the biopsy. The factors associated with EndMT marker expression were DSA and the presence of microvascular inflammation (MI). EndMT expressing grafts had significantly more allograft loss compared to EndMT negative grafts (P
CITATION STYLE
Louis, K., Hertig, A., Taupin, J. L., Buob, D., Jamme, M., Brocheriou, I., … Xu-Dubois, Y. C. (2019). Markers of graft microvascular endothelial injury may identify harmful donor-specific anti-HLA antibodies and predict kidney allograft loss. American Journal of Transplantation, 19(9), 2434–2445. https://doi.org/10.1111/ajt.15340
Mendeley helps you to discover research relevant for your work.